• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mucosal Immunol . Damage sensing through TLR9 regulates inflammatory and antiviral responses during influenza infection

tetano

Editor, Senior Moderator
Mucosal Immunol


. 2025 Jan 28:S1933-0219(25)00008-X.
doi: 10.1016/j.mucimm.2025.01.008. Online ahead of print. Damage sensing through TLR9 regulates inflammatory and antiviral responses during influenza infection

Jooyoung Kim[SUP] 1 [/SUP], Yifan Yuan[SUP] 2 [/SUP], Karen Agaronyan[SUP] 3 [/SUP], Amy Zhao[SUP] 4 [/SUP], Victoria D Wang[SUP] 5 [/SUP], David Gau[SUP] 6 [/SUP], Nicholas Toosi[SUP] 7 [/SUP], Gayatri Gupta[SUP] 4 [/SUP], Heran Essayas[SUP] 4 [/SUP], Ayelet Kaminski[SUP] 4 [/SUP], John McGovern[SUP] 4 [/SUP], Sheeline Yu[SUP] 4 [/SUP], Samuel Woo[SUP] 4 [/SUP], Chris J Lee[SUP] 4 [/SUP], Shifa Gandhi[SUP] 4 [/SUP], Tina Saber[SUP] 4 [/SUP], Tayebeh Saleh[SUP] 5 [/SUP], Buqu Hu[SUP] 4 [/SUP], Ying Sun[SUP] 4 [/SUP], Genta Ishikawa[SUP] 4 [/SUP], William Bain[SUP] 8 [/SUP], John Evankovich[SUP] 5 [/SUP], Lujia Chen[SUP] 9 [/SUP], Hong Duck Yun[SUP] 5 [/SUP], Erica L Herzog[SUP] 4 [/SUP], Charles S Dela Cruz[SUP] 10 [/SUP], Changwan Ryu[SUP] 11 [/SUP], Lokesh Sharma[SUP] 12 [/SUP]



Affiliations
Abstract

Host response aimed at eliminating the infecting pathogen, as well as the pathogen itself, can cause tissue injury. Tissue injury leads to the release of a myriad of cellular components including mitochondrial DNA, which the host senses through pattern recognition receptors. How the sensing of tissue injury by the host shapes the anti-pathogen response remains poorly understood. In this study, we utilized mice that are deficient in toll-like receptor-9 (TLR9), which binds to unmethylated CpG DNA sequences such as those present in bacterial and mitochondrial DNA. To avoid direct pathogen sensing by TLR9, we utilized the influenza virus, which lacks ligands for TLR9, to determine how damage sensing by TLR9 contributes to anti-influenza immunity. Our data show that TLR9-mediated sensing of tissue damage promotes an inflammatory response during early infection, driven by the epithelial and myeloid cells. Along with the diminished inflammatory response, the absence of TLR9 led to impaired viral clearance manifested as a higher and prolonged influenza components in myeloid cells including monocytes and macrophages rendering them highly inflammatory. The persistent inflammation driven by infected myeloid cells led to persistent lung injury and impaired recovery in influenza-infected TLR9-/- mice. Further, we show elevated TLR9 activation in the plasma samples of patients with influenza and its association with the disease severity in hospitalized patients, demonstrating its clinical relevance. Overall, we demonstrate an essential role of damage sensing through TLR9 in promoting anti-influenza immunity and inflammatory response AUTHOR SUMMARY: Tissue damage is an inevitable outcome of clinically relevant lung infections, but the host mechanisms for detecting such damage during infection are not well understood. We investigated the role of Toll-like receptor 9 (TLR9) in sensing tissue damage caused by influenza. Since influenza lacks TLR9 ligands, we hypothesized that TLR9 signaling is driven by tissue damage molecules like mitochondrial DNA (mtDNA). Our data indicate that TLR9 reduces early inflammatory lung injury but impairs viral clearance, resulting in extensive immune cell infection, persistent inflammation, and delayed recovery. Myeloid-specific TLR9 deletion ameliorated late-stage inflammatory responses. In humans, influenza-infected individuals exhibited elevated TLR9 activity and mtDNA levels in plasma compared to healthy controls, with higher TLR9 activation potential correlating with severe disease requiring ICU admission. These findings suggest that TLR9-mediated damage sensing triggers both inflammatory tissue injury and viral clearance. These data indicate that TLR9 activity can serve as a crucial biomarker and therapeutic target to limit influenza induced tissue injury.

Keywords: Inflammation; Influenza; Lung infection; TLR9.

 
Back
Top